Skip to content

Fetuin A Association in Periodontal Disease and Diabetes Mellitus

Evaluation of Fetuin-A and hsCRP Levels in Gingival Crevicular Fluid in Periodontitis Diabetic and Non-Diabetic Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06064786
Enrollment
45
Registered
2023-10-03
Start date
2023-08-01
Completion date
2023-09-15
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis, Adult

Brief summary

Aim: The aim of the current study was to compare and correlate gingival crevicular fluid (GCF) fetuin-A levels and high sensitivity C-reactive protein (hs-CRP) levels in non-diabetic periodontitis patients and type 2 diabetic periodontitis patients with healthy subjects and revealing its possible role in diagnosis of periodontal disease. Methodology: Forty-five periodontitis stage III patients categorized into 3 groups according to whether having type II diabetes mellitus or not were compared to systemically and periodontally healthy participants in this investigation. Clinical parameters for all groups were recorded. Assessment of GCF levels of fetuin A and hs-CRP were done to all enrolled participants utilizing an enzyme linked immune-sorbent assay (ELISA) kit. Receiver operating characteristic (ROC) curve was performed to reveal sensitivity, specificity, predictive value and diagnostic accuracy of the markers used.

Interventions

DIAGNOSTIC_TESTGCF levels of fetuin A and hsCRP evaluation

ELIZA kits are used for GCF levels of fetuin A and hsCRP evaluation

Sponsors

Fayoum University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* both gender periodontitis stage III

Exclusion criteria

1. Smoking, 2. Systemic diseases (except DM in group B), 3. Periodontitis patients having periodontal treatment recently (past 6 months), 4. Pregnancy, lactation, contraceptive pills, 5. Anti-inflammatory/ immunosuppressive drugs.

Design outcomes

Primary

MeasureTime frameDescription
GCF levels of fetuin A and hsCRP evaluation in all groupslevels of fetuin A and hsCRP are measured at baseline after the completion of all GCF sample collection carried at the day of enrollment of subjects in the investigation after diagnosis confirmationELIZA kits

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026